SynthesisTargeted oncology2021

Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis.

Karolina Strzebonska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.